SEC Form 4 · accession 0001093557-18-000090
DEXCOM INC · DXCM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jacob Steven Leach
Officer — SVP, Research & Development
Period of report
May 8, 2018
Accepted (ET)
May 10, 2018 · 7:54 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001093557
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 8, 2018 | M | 1,923 | $3.19 | A | 100,801 | D | |
| Common StockF1 | May 8, 2018 | S | 1,923 | $84.9536 | D | 98,878 | D | |
| Common Stock | May 9, 2018 | M | 8,542 | $9.78 | A | 107,420 | D | |
| Common StockF2,F1 | May 9, 2018 | S | 8,542 | $84.7716 | D | 98,878 | D | |
| Common Stock | May 9, 2018 | M | 203 | $7.27 | A | 99,081 | D | |
| Common StockF2,F1 | May 9, 2018 | S | 203 | $84.7716 | D | 98,878 | D | |
| Common StockF3,F4 | May 8, 2018 | S | 2,500 | $85.1495 | D | 47,600 | I | by Spouse |
| Common StockF5 | holding | — | — | — | 12,000 | I | Family Holdings |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option (right to buy) | $3.19 | May 8, 2018 | M | 1,923 | D | Dec 11, 2009 | Dec 11, 2018 | Common Stock | 1,923 | 0 | D |
| Non-Qualified Stock Option (right to buy) | $7.27 | May 9, 2018 | M | 203 | D | Nov 20, 2010 | Nov 20, 2019 | Common Stock | 203 | 0 | D |
| Non-Qualified Stock Option (right to buy) | $9.78 | May 9, 2018 | M | 8,542 | D | Feb 18, 2011 | Feb 18, 2020 | Common Stock | 8,542 | 0 | D |
Explanation of responses
- F1Included in this number are 56,182 unvested restricted stock units, 30,093 of which were granted on March 8, 2018 and shall vest through March 8, 2021, 15,422 of which were granted on March 8, 2017 and shall vest through March 8, 2020 and 10,667 of which were granted on March 8, 2016 shall vest through March 8, 2019.
- F2This transaction was executed in multiple trades at prices ranging from $84.77 to $84.81. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
- F3This transaction was executed in multiple trades at prices ranging from $85.14 to $85.18. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
- F4Shares are held by the Kyndra S. Leach Trust UAD 12/12/2012, with respect to which the reporting person's spouse is a trustee.
- F5Shares are held by the Gregg Family Grandchildren's Trust UAD 12/30/2010, with respect to which the reporting person's spouse is a trustee.